Sunitinib has demonstrated efficacy for the treatment of patients with neuroendocrine tumours

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1648, 2008-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of gastrointestinal stromal tumours: imatinib, sunitinib – and then?

By Nilsson Bengt Nilsson Ola Ahlman Håkan

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 457-468

Informa Healthcare

Access to resources Recommend Favorite

Urocortin has demonstrated potential as a treatment for heart disease

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Evaluation of Chromogranin A Expression in Patients with Non-Neuroendocrine Tumours

By Tropea F.

Clinical Drug Investigation, Vol. 26, Iss. 12, 2006-01 ,pp. : 715-722

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors

By Bisht Savita Feldmann Georg Brossart Peter

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite

Liraglutide has demonstrated efficacy as an add-on therapy for type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite